Home | BSAAM's Organizer | BSAAM's Sponsor | Contact Us
AACL AACL AACL AACL
BSAAM Logo
AACL Logo
Anti Ageing Conference London 2020
Follow us on ...
Facebook  Twitter  Instagram
Conference Information
Register Info
   
Delegate Information
   
A4M Board Certification
  American Board Of Anti-Aging/Regenerative Medicine (ABAARM)
   
Past Conference Information
  2018
2018 Speakers and Presentations
2018 Programme
2018 Exhibitors

BSAAMs AACL 2018 Peer Review Board Members
  2017
2017 Speakers and Presentations
2017 Programme
2017 Exhibitors

BSAAMs AACL 2017 Peer Review Board Members
  2016
2016 Speakers and Presentations
2016 Programme
2016 Exhibitors
2016 Moderators
BSAAMs AACL 2016 Peer Review Board Members
  2015
2015 Speakers and Presentations
2015 Programme
2015 Exhibitors
2015 Moderators
BSAAMs AACL 2015 Peer Review Board Members
  2014
2014 Speakers and Presentations
2014 Programme
2014 Exhibitors
2014 Moderators
2014 Peer Review Board Members
2014 Aesthetic Peer Review Board Members
  2013
2013 Speakers and Presentations
2013 Programme
2013 Exhibitors
2013 Moderators
2013 Peer Review Board Members
2013 Aesthetic Peer Review Board Members
  2012
2012 Speakers and Presentations
2012 Programme
2012 Exhibitors
2012 Moderators
2012 Peer Review Board Members
2012 Aesthetic Peer Review Board Members
  2011
2011 Speakers and Presentations
2011 Programme
2011 Exhibitors
2011 Moderators
2011 Peer Review Board Members
2011 Aesthetic Peer Review Board Members
  2010
2010 Conference Manual
2010 Speakers and Presentations
2010 Programme
2010 Exhibitors
2010 Moderators
2010 Peer Review Board Members
2010 Aesthetic Peer Review Board Members
  2009
Programme for the 2009
Exhibitors for the 2009
Speakers for the 2009
2009 Peer Review Board Members
2009 Aesthetic Peer Review Board Members
  2008
Programme for 2008
Exhibitors for 2008
Speakers for 2008
2008 Peer Review Board Members
2008 Aesthetic Peer Review Board Members
  2007
  2007 Speaker List
2007 Speaker Programme
  Pre Conference Workshops
Sept 12 Pre-Conference Workshop Programme
Sept 13 Pre-Conference Workshop Programme
  2007 Peer Review Board Members
  Exhibitors for 2007
  2006
  3rd Annual Anti-Ageing Conference Manual (2006)
  Programme for 2006
  ISRM2006 Scientific Board Members
  2006 Peer Review Board Members
  Exhibitors 2006
  2005
  Post Review of 2005
  Remarks about 2005
  Peer Review Board of 2005
  Past Speakers 2005
  2004
  Past Speakers 2004
  2002
  Past Speakers Monte Carlo 2002
   
BSAAM's AACL Organizer
BSAAM
BSAAM Affiliates
waaam
   
   
A4M
   
wosaam
AACL Supporters
HB Health
www.hbhealth.com
   
CPD
   
  BANT
   
 
   
 
   
  Sun Chlorella
   
 
   
enerzona
   
BHMA
   
WOCPM
   
FACE
   
IAAS
   
Dole
   
 
   
 
   
   

AACL 2009 Speaker

Christophe de JaegerDocteur Christophe de Jaeger
Unité de Physiologie de la sénescence - Institut Européen de la Longévité, Paris, France

2009 - HOW TO MEASURE BRAIN AGING

As adults age, central nervous system function slows appreciably. This phenomenon has been assessed with a wide variety of behavioral paradigms and originates from neurobiological factors related to aging. Given the growth of the elderly population and the concomitant increase in the proportion of cognitively impaired individuals, accurate measurement of the mental changes stemming from aging is an important scientific and social problem.

Moreover, because neuroelectric measures have provided some of the most direct evidence for the relationship between central nervous system function and age-related cognitive changes, they have played an increasingly important role in the quantitication and understanding of these effects. A particularly successful application of electrophysiological techniques has employed event-related brain potentials (ERPs). More specifically, the P300 component of the ERP has demonstrated considerable utility in the study of aging because it is thought to result from neural activity associated with attentional and memory processes. For example, P300 amplitude age-variation indexes changes in neural activity across the scalp, the timing of its peak provides a measure of mental processing speed that is independent of behavioral responding, and characterization of its normative values has yielded baseline measures against which cognitive illness can be evaluated.

Even though much progress has been made in the 30 years since the P300 potential was discovered, the primary question remains : What cognitive events does the P300 component reflect? The answer is still uncertain, with the interpretation of the P300 based on neurophysiological investigations of the brain mechanisms that underlie its generation, evidence from experimental studies that manipulate psychological variables, and results obtained from neuropsychological reports that examine the correlational relationships between P300 values and responses from behavioral tests.

The P300 component is often elicited with a simple discrimination task. This procedure has been dubbed the "oddball" paradigm because two stimuli are presented in a random series such that one of them occurs relatively infrequently, that is, the oddball. The auditory version of this task uses two different tones, interstimulus intervals of 1-3 s, and a target stimulus occurring less frequently than the nontarget or standard stimulus (e.g., probabilities of .20 and .80, respectively). The subject is required to distinguish between the two tones by responding to the target (e.g., mentally counting, pressing a button, etc.) and not responding to the standard. This task has been used to study a wide variety of information processing issues and has been the paradigm most often employed when normative aging data are acquired.

The P300 is measured by quantifying its amplitude (size) and latency (timing). Amplitude (ItV) is defined as the voltage difference between a prestimulus baseline and the largest positivegoing peak of the ERP waveform within a latency range (e.g., 250-400 ms, although the range can vary depending on subject characteristics, stimulus modality, task conditions, etc.). Latency (ms) is defined as the time from stimulus onset to the point of maximum positive amplitude within the latency window (with 300 ms being the modal latency when the component is elicited by using auditory stimuli in young adults - hence the name).

 

Home | BSAAM's Organizer | BSAAM's Sponsor | Contact Us
BSAAM's Anti Ageing Conference London, 38 Regent on the River
William Morris Way London SW6 2UT, United Kingdom
Tel: +44 (0)79 7317 3478  Fax: +44 (0)20 7491 0410
Emails :
london@antiageingconference.com
mariasomers@bsaam.com